Factors of Importance for Residual Beta-cell Function in Type I Diabetes Mellitus (Q40154772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Factors of importance for residual beta-cell function in type I diabetes mellitus. A review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Factors of Importance for Residual Beta-cell Function in Type I Diabetes Mellitus (English)

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

4 October 2023

0 references

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

4 October 2023

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6349267

4 October 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1983.tb08549.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1983.tb08549.x/fullpdf

4 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Acta medica Scandinavica. Supplementum

4 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

61-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

Sequential Changes in Beta-Cell Function in Insulin-Treated Diabetic Patients Assessed by C-Peptide Immunoreactivity

10 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Diabetic Ketoacidosis: Evidence for C-Peptide and Proinsulin Secretion following Recovery

4 October 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

4 October 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity

4 October 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement

4 October 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy

4 October 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus

4 October 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies

4 October 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity

4 October 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Hemoglobin A1c (HbA1c) in children with long standing and newly diagnosed diabetes mellitus

4 October 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon

4 October 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Pancreatic Islet-cell Antibodies in Diabetes Mellitus Correlated with the Duration and Type of Diabetes, Coexistent Autoimmune Disease, and HLA Type

4 October 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents

4 October 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Changes in the Islets of Langerhans in Cows Injected with Heterologous and Homologous Insulin

4 October 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Islet-Cell-Surface Antibodies in Juvenile Diabetes Mellitus

4 October 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

C-peptide in children with juvenile diabetes. A preliminary report.

4 October 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

beta-cell function in children with diabetes

4 October 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

C-peptide in children with juvenile diabetes. A preliminary report.

4 October 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

HLA-types, C-peptide and insulin antibodies in juvenile diabetes.

4 October 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

4 October 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.

4 October 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Beta-cell function and metabolic control in insulin treated diabetics.

4 October 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

4 October 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment

4 October 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes

4 October 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

The transient effect of strict glycaemic control on B cell function in newly diagnosed Type 1 (insulin-dependent) diabetic patients

4 October 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.

4 October 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Islet-cell antibodies and beta-cell function in insulin-dependent diabetics

4 October 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Identification of proinsulin and C-peptide in human serum by a specific immunoassay

4 October 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

C-peptide response to arginine stimulation in diabetic children

4 October 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas

4 October 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Effect of insulin antibodies on pancreatic islet insulin and beta cell granule content

4 October 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve

4 October 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

Islet Function in Diabetics with Persistent Islet Cell Antibodies

4 October 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1983.TB08549.X

4 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6349267%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference